Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 16, 2026
Cory Kasimov's Stock Ratings
Evercore ISI Group Analyst
Cory Kasimov is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
18.8%
Smart Score
Overall Average Return Percentile
74th
Number of Ratings
67
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/10/2026 | RVMD | Buy Now | Revolution Medicines | $184.25 | 19.4% | $200 → $220 | Maintains | Outperform | Get Alert | |
| 05/26/2026 | COAG | Buy Now | Hemab Therapeutics Hldgs | $43.30 | 15.47% | → $50 | Initiates | → Outperform | Get Alert | |
| 05/12/2026 | BNTC | Buy Now | Benitec Biopharma | $12.77 | 95.78% | → $25 | Initiates | → Outperform | Get Alert | |
| 05/08/2026 | BBIO | Buy Now | BridgeBio Pharma | $81.62 | 59.27% | $125 → $130 | Maintains | Outperform | Get Alert | |
| 05/05/2026 | BMRN | Buy Now | BioMarin Pharmaceutical | $59.69 | 101.06% | $110 → $120 | Maintains | Outperform | Get Alert | |
| 05/04/2026 | MRNA | Buy Now | Moderna | $66.85 | -25.21% | $35 → $50 | Maintains | In-Line | Get Alert | |
| 04/14/2026 | RVMD | Buy Now | Revolution Medicines | $184.25 | 8.55% | $140 → $200 | Maintains | Outperform | Get Alert | |
| 03/27/2026 | UPB | Buy Now | Upstream Bio | $7.02 | 113.68% | $40 → $15 | Downgrade | Outperform → In-Line | Get Alert | |
| 02/27/2026 | EWTX | Buy Now | Edgewise Therapeutics | $38.53 | 16.79% | $30 → $45 | Maintains | Outperform | Get Alert | |
| 02/25/2026 | BBIO | Buy Now | BridgeBio Pharma | $81.62 | 53.15% | $100 → $125 | Maintains | Outperform | Get Alert | |
| 02/24/2026 | ACLX | Buy Now | Arcellx | — | — | $115 → $115 | Downgrade | Outperform → In-Line | Get Alert | |
| 02/24/2026 | VIR | Buy Now | Vir Biotechnology | $9.61 | 87.3% | $12 → $18 | Maintains | Outperform | Get Alert | |
| 02/17/2026 | MRNA | Buy Now | Moderna | $66.85 | -47.64% | $28 → $35 | Maintains | In-Line | Get Alert | |
| 01/22/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $678.11 | 29.04% | $750 → $875 | Maintains | Outperform | Get Alert | |
| 12/16/2025 | IMNM | Buy Now | Immunome | $22.42 | 78.41% | $18 → $40 | Maintains | Outperform | Get Alert | |
| 11/26/2025 | ZBIO | Buy Now | Zenas BioPharma | $29.25 | 88.03% | → $55 | Initiates | → Outperform | Get Alert | |
| 11/24/2025 | BEAM | Buy Now | Beam Therapeutics | $28.35 | 23.46% | → $35 | Initiates | → Outperform | Get Alert | |
| 11/20/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $10.95 | 128.31% | → $25 | Initiates | → Outperform | Get Alert | |
| 11/18/2025 | UPB | Buy Now | Upstream Bio | $7.02 | 469.8% | → $40 | Initiates | → Outperform | Get Alert | |
| 09/03/2025 | CYTK | Buy Now | Cytokinetics | $80.78 | -0.97% | $60 → $80 | Maintains | Outperform | Get Alert | |
| 09/03/2025 | VIR | Buy Now | Vir Biotechnology | $9.61 | 24.87% | → $12 | Initiates | → Outperform | Get Alert | |
| 08/22/2025 | IMNM | Buy Now | Immunome | $22.42 | -19.71% | → $18 | Initiates | → Outperform | Get Alert | |
| 08/12/2025 | SMMT | Buy Now | Summit Therapeutics | $14.85 | 128.96% | $30 → $34 | Maintains | Outperform | Get Alert | |
| 05/14/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $67.35 | -18.34% | → $55 | Initiates | → Outperform | Get Alert | |
| 05/02/2025 | MRNA | Buy Now | Moderna | $66.85 | -52.13% | $50 → $32 | Maintains | In-Line | Get Alert | |
| 04/24/2025 | NBIX | Buy Now | Neurocrine Biosciences | $170.92 | 8.24% | $190 → $185 | Maintains | Outperform | Get Alert | |
| 03/12/2025 | SMMT | Buy Now | Summit Therapeutics | $14.85 | 102.02% | → $30 | Initiates | → Outperform | Get Alert | |
| 02/12/2025 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $60 → $65 | Maintains | Outperform | Get Alert | |
| 01/27/2025 | MRNA | Buy Now | Moderna | $66.85 | -25.21% | $60 → $50 | Maintains | In-Line | Get Alert | |
| 12/23/2024 | BBIO | Buy Now | BridgeBio Pharma | $81.62 | -38.74% | $45 → $50 | Maintains | Outperform | Get Alert | |
| 12/17/2024 | EWTX | Buy Now | Edgewise Therapeutics | $38.53 | 29.77% | $45 → $50 | Maintains | Outperform | Get Alert | |
| 11/22/2024 | EWTX | Buy Now | Edgewise Therapeutics | $38.53 | 16.79% | → $45 | Initiates | → Outperform | Get Alert | |
| 11/20/2024 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | → $60 | Initiates | → Outperform | Get Alert | |
| 11/19/2024 | BNTX | Buy Now | BioNTech | $91.78 | 36.2% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert | |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.69 | 75.92% | $115 → $105 | Maintains | Outperform | Get Alert | |
| 10/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $678.11 | 73.28% | $1250 → $1175 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | BBIO | Buy Now | BridgeBio Pharma | $81.62 | -44.87% | $50 → $45 | Maintains | Outperform | Get Alert | |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.69 | 92.68% | $113 → $115 | Maintains | Outperform | Get Alert | |
| 06/27/2024 | MRNA | Buy Now | Moderna | $66.85 | 79.51% | $120 → $120 | Maintains | In-Line | Get Alert | |
| 05/14/2024 | ACLX | Buy Now | Arcellx | — | — | → $85 | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | BBIO | Buy Now | BridgeBio Pharma | $81.62 | -38.74% | → $50 | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | NBIX | Buy Now | Neurocrine Biosciences | $170.92 | 2.39% | → $175 | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | MRNA | Buy Now | Moderna | $66.85 | 79.51% | → $120 | Initiates | → In-Line | Get Alert | |
| 05/14/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $678.11 | 69.59% | → $1150 | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.69 | 89.33% | → $113 | Initiates | → Outperform | Get Alert | |
| 05/14/2024 | BNTX | Buy Now | BioNTech | $91.78 | 8.96% | → $100 | Initiates | → In-Line | Get Alert | |
| 02/27/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $30.14 | 191.97% | $84 → $88 | Maintains | Overweight | Get Alert | |
| 06/05/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $260 → $250 | Maintains | Overweight | Get Alert | |
| 02/11/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $30.14 | 337.96% | → $132 | Upgrade | Neutral → Overweight | Get Alert | |
| 01/05/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | → $50 | Initiates | → Overweight | Get Alert | |
| 12/21/2021 | BIIB | Buy Now | Biogen | $206.60 | 33.59% | $324 → $276 | Maintains | Neutral | Get Alert | |
| 09/30/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $162 | Initiates | → Overweight | Get Alert | |
| 03/01/2021 | SANA | Buy Now | Sana Biotechnology | $3.29 | 965.45% | → $35 | Initiates | → Neutral | Get Alert | |
| 02/17/2021 | BLUE | Buy Now | bluebird bio | — | — | $76 → $39 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/12/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $30.14 | 447.45% | → $165 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/29/2020 | AMGN | Buy Now | Amgen | $368.37 | -37.02% | $225 → $232 | Maintains | Neutral | Get Alert | |
| 07/20/2020 | MRNA | Buy Now | Moderna | $66.85 | 33.13% | $60 → $89 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/18/2020 | AMGN | Buy Now | Amgen | $368.37 | -38.92% | $219 → $225 | Maintains | Neutral | Get Alert | |
| 05/06/2020 | INCY | Buy Now | Incyte | $114.12 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $134.44 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 04/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $168 → $163 | Maintains | Overweight | Get Alert | |
| 04/15/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $678.11 | -36.74% | $375 → $429 | Maintains | Neutral | Get Alert | |
| 03/18/2020 | BNTX | Buy Now | BioNTech | $91.78 | -64.04% | → $33 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/14/2020 | ALKS | Buy Now | Alkermes | $51.40 | -59.14% | $25 → $21 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/04/2019 | BNTX | Buy Now | BioNTech | $91.78 | -74.94% | → $23 | Initiates | → Overweight | Get Alert | |
| 10/23/2019 | BIIB | Buy Now | Biogen | $206.60 | 25.85% | $244 → $260 | Maintains | Neutral | Get Alert | |
| 08/29/2019 | AMGN | Buy Now | Amgen | $368.37 | -46.25% | $191 → $198 | Maintains | Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved